Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection
Figure 1
Time course of erythrocyte phosphorylated ribavirin concentration after starting PEG-IFN-2b and ribavirin combination therapy.